Cadila Healthcare has received a Warning Letter issued by the US Food and Drug Administration (USFDA) relating to its Moraiya formulation facility.
The company has taken multiple steps after the inspection to address the observations received from USFDA during the inspection. The company will continue to take all necessary steps to ensure that the USFDA is fully satisfied with its remediation of the said facility. This warning letter does not affect the existing business of the company in the US and the existing product supplies from the Moraiya facility will continue.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
